OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor Activity
Lin Yang, Wenbin Tu, Liyue Huang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10761-10781
Closed Access | Times Cited: 31
Lin Yang, Wenbin Tu, Liyue Huang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10761-10781
Closed Access | Times Cited: 31
Showing 26-50 of 31 citing articles:
Drug Discovery for Chromatin Readers, Writers, Erasers, Remodelers and Epitranscriptomic Targets
Royal Society of Chemistry eBooks (2024)
Closed Access
Royal Society of Chemistry eBooks (2024)
Closed Access
The emergence of pan-KRAS drugs
Darryl B. McConnell, Norbert Kraut
Elsevier eBooks (2024), pp. 311-340
Closed Access
Darryl B. McConnell, Norbert Kraut
Elsevier eBooks (2024), pp. 311-340
Closed Access
Advances in conjugate drug delivery System: Opportunities and challenges
Yishen Zhu, Jiaqi Wu, Feng Zhi
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124867-124867
Closed Access
Yishen Zhu, Jiaqi Wu, Feng Zhi
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124867-124867
Closed Access
Discovery of Potent, Highly Selective, and Efficacious SMARCA2 Degraders
Zhenwu Li, Lalgudi S. Harikrishnan, Guozhang Xu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Zhenwu Li, Lalgudi S. Harikrishnan, Guozhang Xu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Advances in the study of the role of high-frequency mutant subunits of the SWI/SNF complex in tumors
Jiumei Zhao, Jing Zhu, Yu Tang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Jiumei Zhao, Jing Zhu, Yu Tang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Discovery of SMD-3040 as a Potent and Selective Degrader for the Synthetic Lethality Target, SMARCA2
Antonia F. Stepan, Seong Heon Kim
Synfacts (2023) Vol. 19, Iss. 11, pp. 1151-1151
Closed Access
Antonia F. Stepan, Seong Heon Kim
Synfacts (2023) Vol. 19, Iss. 11, pp. 1151-1151
Closed Access
